Get Social

Submit your Twitter account related to Drug-induced Cholestatic Hepatitis to be featured!


Submit your blog on Drug-induced Cholestatic Hepatitis to be featured!


Submit your event on Drug-induced Cholestatic Hepatitis to be featured!


Submit your video on Drug-induced Cholestatic Hepatitis to be featured!


Submit your charity on Drug-induced Cholestatic Hepatitis to be featured!

Drug-induced Cholestatic Hepatitis: Disease Bioinformatics

Drug induced cholestatic liver disease is a subtype of liver injury that is characterized by predominant elevations of alkaline phosphatase and bilirubin secondary to the administration of a hepatotoxic agent. It can manifest itself as a cholestatic hepatitis or as bland cholestasis, depending upon the causative agent and the mechanism of injury. There are certain drugs that cause cholestasis with hepatitis.Drug-induced Cholestatic Hepatitis may present itself as acute at first, but is the most severe manifestation of drug induced liver disease. You cant prevent Drug-induced Cholestatic Hepatitis by being aware fo your drug intake and using them as prescribed.

Drug-induced Cholestatic Hepatitis Bioinformatics Tool

Laverne is a handy bioinformatics tool to help facilitate scientific exploration of related genes, diseases and pathways based on co-citations. Explore more on Drug-induced Cholestatic Hepatitis below! For more information on how to use Laverne, please read the How to Guide.
Vizit™, under license from BioVista Inc.

Top Research Reagents

We have 135 products for the study of Drug-induced Cholestatic Hepatitis that can be applied to Western Blot, Flow Cytometry, Immunocytochemistry/Immunofluorescence, Immunohistochemistry from our catalog of antibodies and ELISA kits.

Immunohistochemistry-Paraffin: Cathepsin G Antibody [NBP2-33498] - bone marrowImmunohistochemistry-Paraffin: Cathepsin G Antibody [NBP2-33498] - Immunohistochemical staining of human bone marrow shows strong cytoplasmic positivity in hematopoietic cells.

Rabbit Polyclonal
Species Human
Applications IHC, IHC-P

Western Blot: GGT1 Antibody (1F9) [H00002678-M01] - GGT1 monoclonal antibody (M01), clone 1F9 Analysis of GGT1 expression in NIH/3T3.Immunohistochemistry-Paraffin: GGT1 Antibody (1F9) [H00002678-M01] - Analysis of monoclonal antibody to GGT1 on formalin-fixed paraffin-embedded human testis. Antibody concentration 3 ug/ml.

Mouse Monoclonal
Species Human, Mouse
Applications WB, ELISA, IHC

5 Publications
Western Blot: GGTLC1 Antibody [NBP1-56928] - Antibody Titration: 5.0ug/ml Positive Control: Human kidneyImmunohistochemistry-Paraffin: GGTLC1 Antibody [NBP1-56928] - Human kidney Tissue, antibody concentration 4-8ug/ml. Cells with positive label: renal corpuscle cells (indicated with arrows) 400X magnification.

Rabbit Polyclonal
Species Human
Applications WB, IHC, IHC-P

Western Blot: Catalase Antibody [NBP2-24916] - Analysis in liver lysate of 1) human 2) mouse and 3) rat at 0.1 ug/ml.Immunohistochemistry-Paraffin: Catalase Antibody [NBP2-24916] - Staining of human liver tissue using an isotype control (top) and this antibody (bottom) at 5 ug/ml.

Rabbit Polyclonal
Species Human, Mouse, Rat
Applications WB, IHC, IHC-P

4 Publications

Related Genes

Drug-induced Cholestatic Hepatitis has been researched against:

Related Pathways

Drug-induced Cholestatic Hepatitis has been linked to:

Related PTMs

Alternate Names

Drug-induced Cholestatic Hepatitis is also known as Drug-induced Cholangiolitic Hepatitis.